Not quite, kiddo. How do you negotiate from a position of strength if you don't have a product that works and clearly shows it works? That's what Gerald is betting on and why they decided not to move earlier to give Lympro away. That was my take away back in Jan when Gerald sprung that during his dinner with investors or where he stated it back in Jan.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.